MAMMONE, GIULIA
 Distribuzione geografica
Continente #
EU - Europa 122
NA - Nord America 117
AS - Asia 21
AF - Africa 1
Totale 261
Nazione #
US - Stati Uniti d'America 114
IT - Italia 66
SE - Svezia 27
DE - Germania 10
CN - Cina 6
SG - Singapore 6
IN - India 5
BG - Bulgaria 4
CA - Canada 3
ES - Italia 3
CZ - Repubblica Ceca 2
FI - Finlandia 2
FR - Francia 2
IE - Irlanda 2
IR - Iran 2
RO - Romania 2
AE - Emirati Arabi Uniti 1
GB - Regno Unito 1
IL - Israele 1
NL - Olanda 1
SC - Seychelles 1
Totale 261
Città #
Chandler 22
Rome 13
Fairfield 11
Ashburn 10
Houston 8
Cambridge 6
New York 6
San Paolo di Civitate 6
Bremen 5
Wilmington 5
Seattle 4
Sofia 4
Woodbridge 4
Beijing 3
Lawrence 3
Milan 3
Princeton 3
Boston 2
Dublin 2
Helsinki 2
Madrid 2
Romainville 2
Rosora 2
Toronto 2
Turin 2
Amsterdam 1
Andover 1
Ann Arbor 1
Arrecife 1
Azor 1
Carlentini 1
Chieti 1
Dubai 1
Edinburgh 1
Fremont 1
Guangzhou 1
Kish 1
Livorno 1
Los Angeles 1
Millbury 1
Mirano 1
Montichiari 1
Montréal 1
Pescara 1
Reggio Calabria 1
Sacramento 1
San Diego 1
Zanjan 1
Totale 155
Nome #
Weekly chemotherapy as first line treatment in frail head and neck cancer patients in the immunotherapy era 80
The impact of locoregional treatment on response to Nivolumab in advanced platinum refractory head and neck cancer: the NEED TRIAL 65
The role of opioids in cancer response to immunotherapy 64
3MO Oncogenic non-G12C {KRAS} mutations in {KRAS} G12C mutated lung adenocarcinomas in {TRACERx} and {GENIE}: A reservoir for intrinsic resistance to {KRAS} G12C inhibitors 41
Comparative effects of Folfirinox and Gemcitabine/nab-paclitaxel as first and second line chemotherapy for metastatic pancreatic cancer: single choice or sequence 31
Real-world Outcome of Patients with Advanced Renal Cell Carcinoma and Intermediate- or Poor-risk International Metastatic Renal Cell Carcinoma Database Consortium Criteria Treated by Immune-oncology Combinations: Differential Effectiveness by Risk Group? 2
Totale 283
Categoria #
all - tutte 1.074
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.074


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202012 0 0 0 0 0 0 0 0 0 8 2 2
2020/202120 0 2 0 1 1 1 0 0 3 5 1 6
2021/202280 23 9 1 3 6 4 1 3 1 5 19 5
2022/2023119 28 21 9 12 16 9 0 7 7 3 7 0
2023/202452 2 4 4 8 4 12 8 5 1 3 1 0
Totale 283